INS and type 2 diabetes mellitus: Dysregulation of SOCS-3 signaling may contribute to the development of type 2 diabetes in obese individuals whose β-cells become resistant to leptin signaling, leading to chronic insulin hypersecretion that eventually causes β-cell failure.